agilon health director granted 2,133 RSUs

Wulf John William reported acquisition or exercise transactions in this Form 4 filing. agilon health, inc. director John William Wulf received an equity award of 2,133 shares in the form of restricted stock units as compensation.

Rhea-AI Filing Summary

Wulf John William reported acquisition or exercise transactions in this Form 4 filing.

agilon health, inc. director John William Wulf received an equity award of 2,133 shares in the form of restricted stock units as compensation. These units vest in full on June 2, 2027, subject to his continued service as a director. After this grant, he beneficially owns 16,765 shares, including restricted stock units, reflecting a 1-for-25 reverse stock split of the company’s common stock that became effective on March 30, 2026.

Insider Trade Summary

Grant/Award: 2,133 shares

Grant/Award 1 txn

Insider Wulf John William

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,133	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,765 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director
2. F2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
3. F3. Includes restricted stock units.

Key Figures

RSU grant size: 2,133 shares Grant price: $0.0000 per share Holdings after grant: 16,765 shares +2 more

5 metrics

RSU grant size 2,133 shares Restricted stock units granted to director on June 2, 2026

Grant price $0.0000 per share Reported acquisition price for the RSU award

Holdings after grant 16,765 shares Beneficial ownership following transaction, including RSUs

Reverse stock split ratio 1-for-25 Split of issued and outstanding common stock effective March 30, 2026

Vesting date June 2, 2027 RSUs vest in full on this date, subject to continued service

Key Terms

restricted stock units, reverse stock split, beneficially owned, common stock

4 terms

restricted stock units financial

"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

reverse stock split financial

"reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

beneficially owned financial

"The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

common stock financial

"reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did agilon health (AGL) director John William Wulf report in this Form 4?

Director John William Wulf reported an equity award of 2,133 restricted stock units. The award represents additional common stock-based compensation and increases his total beneficial ownership to 16,765 shares, including restricted stock units, after the company’s 1-for-25 reverse stock split.

Is the Form 4 transaction for agilon health (AGL) a stock purchase or a grant?

The transaction is a grant of 2,133 restricted stock units, not an open-market stock purchase. The units were acquired at no cash cost per share as part of director compensation and will convert into common shares when they vest, subject to continued board service.

When do John William Wulf’s newly granted agilon health (AGL) restricted stock units vest?

The 2,133 restricted stock units vest in full on June 2, 2027. Vesting is contingent on Wulf’s continued service as a director through that date, meaning he must remain on the board for the units to settle into common shares.

How many agilon health (AGL) shares does John William Wulf own after this Form 4 grant?

Following the grant, Wulf beneficially owns 16,765 shares of agilon health common stock. This total includes restricted stock units and reflects the impact of the company’s 1-for-25 reverse stock split effective March 30, 2026, on his reported holdings.

How did agilon health’s 1-for-25 reverse stock split affect John William Wulf’s reported holdings?

The reverse stock split consolidated every 25 shares into one share, reducing the number of shares outstanding. Wulf’s post-transaction beneficial ownership of 16,765 shares is reported after adjusting for this 1-for-25 split, ensuring his holdings are stated on the new share basis.

Are the agilon health (AGL) restricted stock units reported on this Form 4 included in Wulf’s ownership total?

Yes, the filing states that his beneficially owned amount includes restricted stock units. The 16,765-share total after the transaction therefore combines both currently issued shares and his outstanding restricted stock unit awards tied to agilon health common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 09:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wulf John William

(Last) (First) (Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OHIO 43082

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		A		2,133(1)	A	$0	16,765(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director

2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

3. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)